Logotype for Sonoco Products Company

Sonoco Products Company (SON) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sonoco Products Company

Q4 2024 earnings summary

11 Dec, 2025

Executive summary

  • Completed the Eviosys acquisition on December 4, 2024, expanding global leadership in sustainable metal packaging, and announced the divestiture of Thermoformed and Flexible Packaging (TFP) for $1.8 billion, with most regulatory approvals received and sale completion expected in Q2 2025.

  • Integration of Eviosys is underway, targeting $100 million in synergies over two years, with about one-third expected in 2025 and the remainder in 2026.

  • Strategic focus is on core Metal and Paper Packaging, Consumer, and Industrial businesses, with ongoing review of the ThermoSafe cold chain and resin-based businesses.

  • Transformation to "Fewer, Bigger Businesses" and portfolio simplification continued, with strong productivity gains offsetting price/cost headwinds and operational impacts from hurricanes in early Q4.

Financial highlights

  • Q4 adjusted EBITDA increased 5% year-over-year to $247 million, with margin expanding to 14.9%; Q4 net sales from continuing operations rose 2% to $1.36 billion.

  • Adjusted EPS (excluding Eviosys) was $1.17, within the lower end of guidance; including Eviosys, adjusted EPS was $1.00 due to interest expense.

  • Full-year operating cash flow was $834 million, and free cash flow reached $456 million, the second-best in company history.

  • Year-to-date 2024 net sales were $5.31 billion, down 2.5%-3% from 2023; full-year adjusted EBITDA was $1.04 billion, down 3.1%.

  • Capital expenditures totaled $378 million in 2024, focused on growth and productivity.

Outlook and guidance

  • 2025 sales projected at $7.75–$8.0 billion, up 21.5%, driven by the full-year Eviosys contribution and organic growth.

  • 2025 adjusted EPS guidance is $6.00–$6.20, up 19%-23% from 2024, with Eviosys expected to contribute $0.85–$0.90.

  • Adjusted EBITDA for 2025 projected at $1.3–$1.4 billion; operating cash flow guidance is $750–$900 million; free cash flow $450–$550 million.

  • Capital expenditures for 2025 planned at $360–$450 million, with a higher emphasis on debt repayment and value-added projects.

  • Focus on integrating Eviosys, achieving $100 million in synergies, and reducing leverage to 3.0x–3.3x by end of 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more